TCL Archive NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade May 2, 2014
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003